Perspective Chapter: New Use of the SSRI Fluvoxamine in the Treatment of COVID-19 Symptoms
From the perspective of repurposing medication, recent evidence suggests that the use of selective serotonin reuptake inhibitor antidepressants (SSRIs) can help reduce the severity of symptoms and death associated with SARS-CoV-2 infection. To focus more, COVID-19 is a viral disease with potentially...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/81906 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Perspective Chapter: New Use of the SSRI Fluvoxamine in the Treatment of COVID-19 Symptoms
- Perspective Chapter: Ketamine, Depression, and Gender Bias
- New Perspective and Applications of Homeopathy in Treating COVID-19 Symptoms
- Perspective Chapter: Temporomandibular Joint Disorders – New Perspectives in Diagnosis and Treatment
- Introductory Chapter: Endometriosis - Recent Advances, New Perspectives and Treatments
- Perspective Chapter: The Cardiovascular Impact of COVID-19
- Perspective Chapter: Psychological Effects of COVID-19 Pandemic